BioCentury
ARTICLE | Company News

NTT, Synvista deal

January 21, 2008 8:00 AM UTC

Novel will develop a topical cream formulation of ALT-2074 to treat psoriasis for Synvista. Synvista plans to start an Israeli Phase II trial of the new formulation to treat plaque psoriasis in mid-2...